ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 145 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,412,739 | +1020.7% | 133,571 | +1158.0% | 0.00% | – |
| Q2 2023 | $304,524 | +28.5% | 10,618 | +7.4% | 0.00% | – |
| Q1 2023 | $236,920 | -44.9% | 9,884 | -61.0% | 0.00% | – |
| Q4 2022 | $429,869 | +9.9% | 25,346 | -3.8% | 0.00% | – |
| Q3 2022 | $391,000 | -5.1% | 26,334 | +0.7% | 0.00% | – |
| Q2 2022 | $412,000 | -29.7% | 26,157 | +20.3% | 0.00% | – |
| Q1 2022 | $586,000 | +91.5% | 21,740 | +163.0% | 0.00% | – |
| Q4 2021 | $306,000 | -33.3% | 8,267 | -13.8% | 0.00% | – |
| Q3 2021 | $459,000 | +55.6% | 9,593 | +9.6% | 0.00% | – |
| Q2 2021 | $295,000 | +26.1% | 8,754 | +54.3% | 0.00% | – |
| Q1 2021 | $234,000 | -35.4% | 5,675 | -32.6% | 0.00% | – |
| Q3 2020 | $362,000 | -96.5% | 8,414 | -96.2% | 0.00% | -100.0% |
| Q2 2020 | $10,325,000 | – | 220,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DFPG INVESTMENTS, LLC | 183,803 | $9,359,000 | 5.00% |
| DAFNA Capital Management LLC | 229,652 | $9,852,000 | 3.20% |
| HealthCor Management, L.P. | 1,594,452 | $68,402,000 | 2.74% |
| Capital Impact Advisors, LLC | 110,000 | $4,719,000 | 1.40% |
| Cormorant Asset Management, LP | 700,000 | $30,030,000 | 1.16% |
| ARK Investment Management | 2,495,842 | $107,072,000 | 0.64% |
| Millrace Asset Group, Inc. | 18,087 | $776,000 | 0.63% |
| COOPER CREEK PARTNERS MANAGEMENT LLC | 50,532 | $2,168,000 | 0.54% |
| Endurant Capital Management LP | 34,485 | $1,479,000 | 0.44% |
| HealthCor Management, L.P. | 200,000 | $8,580,000 | 0.34% |